Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi Fang Yan

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Annals of the New York Academy of Sciences|January 4, 2012
Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complicationsRavichandran Ramasamy, Shi Fang Yan, Ann Marie Schmidt
Circulation Research|March 20, 2010
The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculatureShi Fang Yan, Ravichandran Ramasamy, Ann Marie Schmidt
Nature Clinical Practice. Endocrinology & Metabolism|March 12, 2008
Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complicationsShi Fang Yan, Ravichandran Ramasamy, Ann Marie Schmidt
Trends in Cardiovascular Medicine|October 18, 2005
The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyondRavichandran Ramasamy, Shi Fang Yan, Ann Marie Schmidt
Journal of Molecular Medicine (Berlin, Germany)|February 4, 2009
Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory responseShi Fang Yan, Ravichandran Ramasamy, Ann Marie Schmidt
Circulation Research|December 13, 2003
Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyondShi Fang Yan, Ravichandran Ramasamy, Yoshifumi Naka, et al.
Current Molecular Medicine|March 12, 2008
Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & agingShi Fang Yan, Vivette D'Agati, Ann Marie Schmidt, et al.
Trends in Endocrinology and Metabolism: TEM|September 29, 2009
RAGE, glomerulosclerosis and proteinuria: roles in podocytes and endothelial cellsVivette D'Agati, Shi Fang Yan, Ravichandran Ramasamy, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2018
Identification and Characterization of Amyloid-β Accumulation in Synaptic MitochondriaShi Fang Yan, Firoz Akhter, Alexander A Sosunov, et al.
Annals of Medicine|March 27, 2009
Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammationShi Fang Yan, Shi Du Yan, Ravichandran Ramasamy, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Annals of the New York Academy of Sciences|January 4, 2012
Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complicationsRavichandran Ramasamy, Shi Fang Yan, Ann Marie Schmidt
Circulation Research|March 20, 2010
The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculatureShi Fang Yan, Ravichandran Ramasamy, Ann Marie Schmidt
Nature Clinical Practice. Endocrinology & Metabolism|March 12, 2008
Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complicationsShi Fang Yan, Ravichandran Ramasamy, Ann Marie Schmidt
Trends in Cardiovascular Medicine|October 18, 2005
The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyondRavichandran Ramasamy, Shi Fang Yan, Ann Marie Schmidt
Journal of Molecular Medicine (Berlin, Germany)|February 4, 2009
Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory responseShi Fang Yan, Ravichandran Ramasamy, Ann Marie Schmidt
Circulation Research|December 13, 2003
Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyondShi Fang Yan, Ravichandran Ramasamy, Yoshifumi Naka, et al.
Current Molecular Medicine|March 12, 2008
Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & agingShi Fang Yan, Vivette D'Agati, Ann Marie Schmidt, et al.
Trends in Endocrinology and Metabolism: TEM|September 29, 2009
RAGE, glomerulosclerosis and proteinuria: roles in podocytes and endothelial cellsVivette D'Agati, Shi Fang Yan, Ravichandran Ramasamy, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2018
Identification and Characterization of Amyloid-β Accumulation in Synaptic MitochondriaShi Fang Yan, Firoz Akhter, Alexander A Sosunov, et al.
Annals of Medicine|March 27, 2009
Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammationShi Fang Yan, Shi Du Yan, Ravichandran Ramasamy, et al.
Pageof 9